PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer

PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer

Background: In patients with oligometastatic recurrent prostate cancer, standard treatment is androgen deprivation therapy (ADT). However, ADT has many potential side effects that may result in impaired quality of life. Early identification to select patients suitable for stereotactic ablative radio...

Full description

Bibliographic Details
Main Authors: Charlotte L. Deijen, Gerbert L. Vrijenhoek, Eva E. Schaake, Wouter V. Vogel, Luc M.F. Moonen, Floris J. Pos, Henk G. van der Poel, Gerben R. Borst
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Prostate cancer
SABR
Oligometastases
Androgen deprivation therapy
PSMA-11-PET
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630821000616

Internet

http://www.sciencedirect.com/science/article/pii/S2405630821000616

Similar Items